Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia

Creative Commons License

Garcia-Portilla M. P., Llorca P., Maina G., Bozikas V. P., Devrimci-Ozguven H., Kim S., ...More

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, vol.10, 2020 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 10
  • Publication Date: 2020
  • Doi Number: 10.1177/2045125320926347
  • Journal Name: THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), EMBASE, Directory of Open Access Journals
  • Keywords: functional remission, paliperidone palmitate 3-monthly formulation, paliperidone palmitate 1-monthly formulation, schizophrenia, symptomatic remission, QUALITY-OF-LIFE, ANTIPSYCHOTIC MEDICATION, MAINTENANCE TREATMENT, NATIONWIDE COHORT, NEGATIVE SYNDROME, REMISSION, RISPERIDONE, CARE, DISCONTINUATION, PREDICTORS
  • Open Archive Collection: AVESIS Open Access Collection
  • Ankara University Affiliated: Yes

Abstract

Background: